Iovance: Approval For Solid Tumor Targeting TIL Therapy Likely, Outlook Promising (IOVA) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The "Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update".
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 5,350,000 shares, a decrease of 23.1% from the December 15th total of 6,960,000 shares. Based on an average trading volume of 1,560,000 shares, the short-interest ratio is […]